Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Is it safe or cost-effective to import medicine from Canada's or other countries' drug supplies?

 

Pharmacy to pharmacy marketplaces for medicine have been used to traffick counterfeits. PSM is urging better safety measures

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

Pill press update: January through June 2025

July 16, 2025

Pill presses and molds are used to make fake pills with deadly consequences thousands of people every year. The number of Americans that take fake pills annually without a fatal event is even higher. Read our January through June 2025 report covering pill press seizures, policy developments, and legislation.

July 14, 2025: Counterfeit Keytruda peddlers sentenced in federal court

July 14, 2025
Boxes labeled Keytruda 50mg stacked on a white surface

Avanish Kumar Jha and Rajnish Kumar Jha got 30-month sentences for selling counterfeit medicines—including vials of fake Keytruda—to U.S. buyers.

An FDA inspection revealed significant problems at Empower’s new outsourcing facility

July 14, 2025

After a November 2024 inspection, the FDA issued a Form 483 to Empower Clinic Services highlighting violations related to compounded drug manufacturing practices at its East Windsor, New Jersey facility.

July 7, 2025: Google to block promotion of pill presses on ads and shopping platforms

July 8, 2025
Pill press listings on Google Shopping from July 2025

The change will affect the Google Ads and Google Shopping platforms starting in September 2025.

FDA announces changes to section 804 importation program proposals

July 7, 2025

A July 1, 2025 post clarifies that applicants can use “a static baseline approach for the cost-savings analysis” instead of trying to account for changes in unpredictable markets.

June 30, 2025: Operation Pangea XVII nets $65 million in unapproved and counterfeit medicines

June 30, 2025

The operation launched 1,728 investigations in 91 countries and shut down 13,000 criminal-linked websites, social media pages, channels, and bots used to market and sell illegal or counterfeit medicines.

PSM writes to support changes to FDA’s Medwatch reporting system

June 30, 2025

On June 26, PSM commented in support proposed revisions to forms FDA 3500 and FDA 3500B, which are used to report adverse events from prescription and over-the-counter medicines.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

Who's investigating a company selling research-grade weight loss injections?  Find out..

Updates on two federal prosecutions.

youtube-video-thumbnail

Click the images below to see more recent videos.